HomeCompareAHRN vs JNJ

AHRN vs JNJ: Dividend Comparison 2026

AHRN yields 19.07% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AHRN wins by $48.9K in total portfolio value
10 years
AHRN
AHRN
● Live price
19.07%
Share price
$10.49
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$68.9K
Annual income
$6,091.52
Full AHRN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AHRN vs JNJ

📍 AHRN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAHRNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AHRN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AHRN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AHRN
Annual income on $10K today (after 15% tax)
$1,620.58/yr
After 10yr DRIP, annual income (after tax)
$5,177.79/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, AHRN beats the other by $4,474.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AHRN + JNJ for your $10,000?

AHRN: 50%JNJ: 50%
100% JNJ50/50100% AHRN
Portfolio after 10yr
$44.5K
Annual income
$3,459.65/yr
Blended yield
7.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AHRN
No analyst data
Altman Z
45.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AHRN buys
0
JNJ buys
0
No recent congressional trades found for AHRN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAHRNJNJ
Forward yield19.07%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$68.9K$20.0K
Annual income after 10y$6,091.52$827.78
Total dividends collected$38.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AHRN vs JNJ ($10,000, DRIP)

YearAHRN PortfolioAHRN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,607$1,906.56$10,676$355.77+$1.9KAHRN
2$15,735$2,246.28$11,407$389.39+$4.3KAHRN
3$19,457$2,620.34$12,198$426.53+$7.3KAHRN
4$23,847$3,028.15$13,056$467.62+$10.8KAHRN
5$28,985$3,468.60$13,987$513.12+$15.0KAHRN
6$34,954$3,940.10$14,998$563.56+$20.0KAHRN
7$41,842$4,440.66$16,098$619.52+$25.7KAHRN
8$49,738$4,967.90$17,295$681.69+$32.4KAHRN
9$58,739$5,519.16$18,599$750.82+$40.1KAHRN
10$68,943$6,091.52$20,022$827.78+$48.9KAHRN

AHRN vs JNJ: Complete Analysis 2026

AHRNStock

Ahren Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and complete a business combination with a company fueled by deep technology and/or deep science. The company was incorporated in 2021 and is based in Grand Cayman, the Cayman Islands.

Full AHRN Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AHRN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AHRN vs SCHDAHRN vs JEPIAHRN vs OAHRN vs KOAHRN vs MAINAHRN vs ABBVAHRN vs MRKAHRN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.